KiroTAC

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameKiroTAC
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungBreast NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKiromic Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKiromic Biopharma Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungBreast NeoplasmsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A